NCT07515274

Brief Summary

This is a category 2 human research study (RIPH), interventional, single-center, prospective, open-label. The primary objective of this study is to qualitatively assess the effects of equicoaching on social reintegration in young adults who have been treated for cancer. The secondary objectives are to evaluate the contribution of equicoaching to:

  1. 1.Self-confidence;
  2. 2.Well-being
  3. 3.Quality of life Satisfaction with equicoaching will also be evaluated.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
9mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress11%
Apr 2026Jan 2027

First Submitted

Initial submission to the registry

December 2, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

April 5, 2026

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 7, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2027

Last Updated

April 13, 2026

Status Verified

April 1, 2026

Enrollment Period

6 months

First QC Date

December 2, 2025

Last Update Submit

April 7, 2026

Conditions

Keywords

cancer pediatric

Outcome Measures

Primary Outcomes (1)

  • social reintegration

    Social reintegration will be assessed using a qualitative comparative analysis of two individual semi-structured interviews conducted at baseline and six months after the intervention. Interview topics will include illness trajectory, social and family relationships, level of autonomy and independence, ability to plan for the future, social participation, and participants' perceptions of the equicoaching intervention. All interviews will be audio-recorded, transcribed verbatim, and analyzed using thematic analysis with NVivo software to identify changes in themes and subthemes over time.

    Inclusion and month 6

Secondary Outcomes (3)

  • Self-confidence

    Inclusion and month 6

  • Well-being

    Inclusion and month 6

  • emotional functioning subscale of Quality of life

    Inclusion and month 6

Study Arms (1)

intervention EQUICAP

EXPERIMENTAL
Procedure: equicoaching

Interventions

equicoachingPROCEDURE

An initial individual interview will be organized with each participant to discuss their experience of the disease, their social relationships, their leisure activities, their relationship with horses, and their relationship with sports, exploring their experiences and practices in physical activities. Questionnaires to assess quality of life, well-being, and self-confidence will be completed during this interview. This will be followed by equicoaching. This intervention will be carried out by two qualified professionals over a period of six months and will consist of six monthly group sessions combined with individual follow-up. This will be followed by equicoaching. This intervention will be carried out by two qualified professionals over a period of six months and will consist of six monthly group sessions combined with monthly individual follow-up via videoconference. The various group sessions will address different topics. After each group session, the AJAs will have individual i

intervention EQUICAP

Eligibility Criteria

Age15 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Have been treated for a malignant oncological or hematological condition.
  • Be between 15 and 25 years of age at the time of cancer diagnosis. This age range corresponds to that chosen by the Leon Berard Cancer Center (CLB) and the Institute of Pediatric Hematology and Oncology (IHOPe) for the Adolescents and Young Adults with Cancer (DAJAC) program
  • Have been treated at IHOPe/CLB as part of the DAJAC program
  • Have completed intensive treatment within the last twelve months.
  • Be able to understand, read, and write French
  • Be affiliated with a health insurance plan
  • Have been informed about the study and have given consent
  • For minors:
  • All of the above criteria
  • Parent/legal guardian informed about the study and having given consent

You may not qualify if:

  • Patient deprived of liberty by judicial or administrative decision
  • Pregnant or breastfeeding women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CLB

Lyon, France

Location

MeSH Terms

Conditions

Neoplasms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 2, 2025

First Posted

April 7, 2026

Study Start

April 5, 2026

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

January 31, 2027

Last Updated

April 13, 2026

Record last verified: 2026-04

Locations